Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Sarah Rodriguez

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Rodriguez, Sarah

PropertyValue
keywords Retinopathy of Prematurity
overview Sarah Rodriguez, MD, MPH, provides comprehensive, compassionate care to children with decreased vision in one or both eyes. Dr. Rodriguez has expertise in treating conditions caused by abnormal eye development, such as amblyopia (lazy eye), strabismus (misalignment of the eyes), pediatric cataracts, and retinopathy of prematurity (ROP). She also specializes in adjustable sutures for adult strabismus / realignment surgery.   Dr. Rodriguez is not only passionate about delivering high-quality care to her patients, but she is also actively involved in clinical research. She received the prestigious Knights Templar Eye Foundation Career-Starter Grant to study neurodevelopmental outcomes among infants screened for ROP, and she is the Principle Investigator for the University of Chicago's involvement in the Pediatric Eye Disease Investigator Group (PEDIG). Dr. Rodriguez's research has been published in a number of scientific journals, including Ophthalmology, Pediatrics, and the Journal of the American Association for Pediatric Ophthalmology and Strabismus (J AAPOS). She is currently an Editorial Board member for J AAPOS. Having completed several medical mission trips to Ghana and Nicaragua, she also has an interest in health disparities and global health. She participated in ROP workshops in Vietnam and South Africa, and she is a committee member for a program dedicated to preventing the next anticipated wave of ROP in Sub-Saharan Africa called SIBA (Stop Infant Blindness in Africa).

One or more keywords matched the following items that are connected to Rodriguez, Sarah

Item TypeName
Concept Infant, Premature
Concept Infant, Premature, Diseases
Academic Article Bevacizumab or laser for aggressive posterior retinopathy of prematurity.
Grant Core Grant: Using a Commercial Claims Database to Evaluate Outcomes Related to Retinopathy of Prematurity.
Grant Diversity Grant: Assessing Socioeconomic Status as a Risk Factor for Severe Retinopathy of Prematurity
Grant Evaluating the efficacy of a smartphone application (Baby Moves!) to detect developmental delays among a high risk population of infants screened for retinopathy of prematurity.
Grant Core Grant: Using a Commercial Claims Database to Evaluate Outcomes Related to Retinopathy of Prematurity
Academic Article Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226).
Academic Article Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity.
Academic Article Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP.
Academic Article Reply to comment on: "Advantages of bevacizumab for aggressive posterior retinopathy of prematurity".
Academic Article Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP.
Academic Article Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment.
Academic Article Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity.
Academic Article The early gut microbiome could protect against severe retinopathy of prematurity.
Academic Article Two-Year Outcomes Comparing Anti-VEGF Injections to Laser for ROP Using a Commercial Claims Database.
Academic Article A Potential Solution to Plus Disease Variability.
Academic Article Macular Sequelae Following Exudative Retinal Detachment After Laser Photocoagulation for Retinopathy of Prematurity.
Academic Article Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis.

Search Criteria
  • Infant Premature